Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Colorectal Neoplasms 35Glioblastoma 24Carcinoma, Non-Small-Cell Lung 21Ovarian Neoplasms 14Carcinoma, Hepatocellular 14Brain Neoplasms 14Carcinoma, Renal Cell 13Pancreatic Neoplasms 12Neoplasms 10Neoplasm Metastasis 10Glioma 10Breast Neoplasms 10Colonic Neoplasms 8Astrocytoma 8Melanoma 7Uterine Cervical Neoplasms 6Rectal Neoplasms 6Liver Neoplasms 6Gliosarcoma 6Endometrial Neoplasms 6Stomach Neoplasms 5Lung Neoplasms 5Fallopian Tube Neoplasms 5Colorectal Cancer Metastatic 5Advanced Solid Tumors 5Squamous Cell Carcinoma of Head and Neck 4Prostatic Neoplasms 4Oligodendroglioma 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3

Interventions

fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Cyclosporine 3Whole-Body Irradiation 2Cord Blood Stem Cell Transplantation 2Vorinostat 1Vitamin E 1Topotecan 1Radiotherapy 1ON 01910 1Microarray Analysis 1Isotretinoin 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cytarabine 1Cyclosporins 1Cyclophosphamide 1Busulfan 1Bevacizumab 1Azacitidine 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Anemia, Refractory × Bevacizumab × Clear all
NCT00022048 2013-05-15

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 1/2 Completed
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡